Frontlight ResearchEarly access
Colorectal cancer trials in United States
551 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEfficacy of Perioperative Opioid Sparing Techniques on Time to Initiation of Chemotherapy
- Where
- Knoxville
- Age
- 18 years to 80 years
- People
- 200
- Run by
- University of Tennessee Graduate School of Medicine
See details and how to joinNCT07153614 - Phase 1/2Taking people64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
- Where
- Cincinnati, Duarte, Grand Rapids, Orange, Stanford
- Age
- 15 years and over
- People
- 26
- Run by
- Lantheus Medical Imaging
See details and how to joinNCT06298916 - No phaseTaking peoplePilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
- Where
- Morrisville
- Age
- 18 years and over
- People
- 2,700
- Run by
- Mainz Biomed
See details and how to joinNCT06864338 - No phaseTaking peopleEffects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer
- Where
- Orlando
- Age
- 18 years and over
- People
- 70
- Run by
- AdventHealth Translational Research Institute
See details and how to joinNCT05789433 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Boston, Chapel Hill, Hershey, Los Angeles, Madison, Tampa
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - No phaseTaking peopleColoCare Study - Colorectal Cancer Cohort
- Where
- Knoxville, Los Angeles, Salt Lake City, Seattle, St Louis, Tampa
- Age
- 18 years to 89 years
- People
- 5,000 worldwide
- Run by
- University of Utah
See details and how to joinNCT02328677 - Phase 2Taking peoplePhase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER
- Where
- Houston
- Age
- 18 years to 80 years
- People
- 28
- Run by
- Baylor College of Medicine
See details and how to joinNCT05870800 - No phaseTaking peopleTempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
- Where
- Appleton, Bethesda, Canton, Cincinnati, Columbus, Fort Smith, Fountain Valley, Goldsboro, Joplin, Oklahoma City, Omaha, Salt Lake City, Seattle, Springfield, St Louis, Toledo, York
- Age
- 18 years and over
- People
- 300
- Run by
- Tempus AI
See details and how to joinNCT05234177 - No phaseTaking peoplePreserving Fertility After Colorectal Cancer Study
- Where
- Nashville
- Age
- 18 years to 49 years
- People
- 1,000
- Run by
- Andreana Holowatyj, PhD, MSCI
See details and how to joinNCT05239338 - Phase 1/2Active, not recruitingStudy of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
- Where
- San Antonio, Spokane, Tyler
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- TiumBio Co., Ltd.
See details and how to joinNCT05784688 - Early phase 1Not yet taking people in United StatesLipid Mediators & Cancer: Montelukast, SPM, and Almonds
- Where
- Tampa
- Age
- 18 years and over
- People
- 56
- Run by
- University of South Florida
See details and how to joinNCT06887673 - No phaseTaking peopleA Multicenter Cancer Biospecimen Collection Study
- Where
- San Francisco
- Age
- 18 years and over
- People
- 1,650
- Run by
- Cofactor Genomics, Inc.
See details and how to joinNCT04510129 - Phase 1/2Taking peopleA Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- Where
- Boston, Denver, Detroit, Fairfax, Fort Myers, Houston, Indianapolis, Los Angeles, Nashville, New Haven, New York, Portland
- Age
- 18 years and over
- People
- 365
- Run by
- GV20 Therapeutics
See details and how to joinNCT05669430 - No phaseTaking peopleProspective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
- Where
- Austin
- Age
- 40 years and over
- People
- 5,000
- Run by
- Natera, Inc.
See details and how to joinNCT06620627 - Phase 2Taking peopleA Study of IBI363 in Subjects with Advanced Solid Malignancies
- Where
- Dearborn, Fairway, Houston, Ocala, Plantation, San Francisco, Seattle, Troy
- Age
- 18 years and over
- People
- 178
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT06281678 - No phaseTaking peopleUrine Metabolites in the Diagnosis of Disease
- Where
- Encinitas, Santa Monica, Walnut Creek
- Age
- 18 years and over
- People
- 1,250
- Run by
- Luventix, Inc.
See details and how to joinNCT06710067 - Phase 1/2Taking peopleA Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Where
- Cleveland, Jacksonville, New York, Rochester, Scottsdale
- Age
- 18 years and over
- People
- 358 worldwide
- Run by
- GI Innovation, Inc.
See details and how to joinNCT05824975 - Phase 2Taking peopleEvaluation of Gixam's Performance in a FIT Negative Population
- Where
- Portland
- Age
- 45 years to 85 years
- People
- 400
- Run by
- Jubaan Ltd.
See details and how to joinNCT06612281 - No phaseTaking peopleThe DRAGON 2 Trial
- Where
- New Haven
- Age
- 18 years and over
- People
- 348 worldwide
- Run by
- Maastricht University
See details and how to joinNCT05428735 - Phase 3Taking peoplePerformance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
- Where
- Boston, Duarte, La Jolla, Philadelphia, Weston, Worcester
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Surgimab
See details and how to joinNCT03659448 - Phase 1Taking peopleA First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
- Where
- Dallas, Fairfax
- Age
- 18 years and over
- People
- 38
- Run by
- Hefei TG ImmunoPharma Co., Ltd.
See details and how to joinNCT05746897 - Phase 2Taking peopleCPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- Where
- Chicago
- Age
- 18 years and over
- People
- 94
- Run by
- Northwestern University
See details and how to joinNCT05733000 - No phaseTaking peopleFeasibility of Non-Operative Management of Rectal Cancer in a Rural Population
- Where
- Cooperstown
- Age
- 18 years and over
- People
- 50
- Run by
- Bassett Healthcare
See details and how to joinNCT04245683 - Phase 1Not yet taking people in United StatesStudy of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
- Where
- Jacksonville, Tampa
- Age
- 18 years and over
- People
- 34 worldwide
- Run by
- Celyad Oncology SA
See details and how to joinNCT04991948 - No phaseNot yet taking people in United StatesMonitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 39 worldwide
- Run by
- Institut Paoli-Calmettes
See details and how to joinNCT03961776